-
-
-
-
-
-
-
iShares Nasdaq Biotechnology (IBB) call put ratio 2.4 calls to 1 put into the annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
iShares Nasdaq Biotechnology (IBB) option IV at low end of range
-
-
-
-
-
-
-
iShares Nasdaq Biotechnology (IBB) puts more active than calls after pull back
-
-
-
-
-
-
-
iShares Nasdaq Biotechnology (IBB) IV flat, shares near record high
-
-
-
-
-
-
-
iShares Nasdaq Biotechnology (IBB) IV at 33 into shares trending up from March pullback
-
-
-
-
-
-
-
iShares Nasdaq Biotechnology (IBB) Health Care Select Sect Fd (XLV) option implied volatility flat to low, shares near record high
-
-
-
-
-
-
-
iShares Nasdaq Biotechnology (IBB) puts after Biogen (BIIB) discontinues two Alzheimer's trials
-
91,808 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

